[1] |
TIAN Chen, LIU Jianing, TIAN Jinhui, GE Long.
Living Systematic Reviews: Methods and Processes for Development
[J]. Chinese General Practice, 2025, 28(30): 3853-3860.
|
[2] |
WANG Tingting, TANG Yong, ZHANG Wenke, LI Zhigang.
Research Progress on Exercise Intervention of Hyperuricemia
[J]. Chinese General Practice, 2025, 28(30): 3841-3846.
|
[3] |
ZHOU Sheng, DENG Changsheng, ZOU Guanyang, SONG Jianping.
Research Progress on the Pathogenesis of Complications of Malaria in Cardiovascular Diseases
[J]. Chinese General Practice, 2025, 28(27): 3466-3472.
|
[4] |
ZHANG Yunuo, LI Ruibin, WANG Wei.
Correlation Analysis of Serum Nesfatin-1 and Ghrelin Levels with Glycolipid Metabolism and Type 2 Diabetes Mellitus
[J]. Chinese General Practice, 2025, 28(26): 3264-3270.
|
[5] |
HUANG Yulin, WANG Haoyun, LI Yanmei, XIAO Xueying.
Symptom Clusters in Gastric Cancer Patients Receiving Chemotherapy: a Scoping Review
[J]. Chinese General Practice, 2025, 28(26): 3338-3344.
|
[6] |
ZHANG Ruimin, DONG Zheyi, LI Shuang, WANG Qian, CHEN Xiangmei.
Traditional Chinese Medicine Factors Associated with Diabetic Nephropathy Diagnosed by Renal Biopsy
[J]. Chinese General Practice, 2025, 28(26): 3307-3313.
|
[7] |
TANG Shangfeng, HUANG Yangzhen, ZHENG Yanxi, PAN Yangyang, XIONG Zhongbao, QING Hua, SONG Jia, WEI Yilin, DONG Heng, WANG Chunying, CHEN Manwei, ZHANG Kangkang.
Specification for the Integration of Healthcare and Prevention Services in Diabetes at the Primary Level
[J]. Chinese General Practice, 2025, 28(25): 3096-3103.
|
[8] |
YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan.
Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes
[J]. Chinese General Practice, 2025, 28(24): 3053-3058.
|
[9] |
LIU Yinyin, SUI Hongping, LI Tingting, JIANG Tongtong, SHI Tieying, XIA Yunlong.
Advances in Risk Prediction Models for Cardiotoxicity Associated with Breast Cancer Treatment
[J]. Chinese General Practice, 2025, 28(24): 3072-3078.
|
[10] |
WANG Rupeng, NAN Jing, HU Yiran, YANG Shenghua, JIN Zening.
Predictive Value of the Triglyceride-Glucose Body Mass Index for Slow Flow/No-reflow Phenomenon in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention
[J]. Chinese General Practice, 2025, 28(24): 2985-2992.
|
[11] |
LI Miaoxiu, ZHU Bowen, KONG Lingjun, FANG Min.
Progress in Research on Clinical Assessment Tools for Conservative Treatment of Adolescent Idiopathic Scoliosis
[J]. Chinese General Practice, 2025, 28(24): 3079-3088.
|
[12] |
XIAO Yao, WAN Jun.
Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants
[J]. Chinese General Practice, 2025, 28(24): 3066-3071.
|
[13] |
RUAN Wanbai, LI Junfeng, YIN Yanmei, PENG Lei, ZHU Kexiang.
Research Progress of Targeted Therapy and Immunotherapy for Pancreatic Cancer
[J]. Chinese General Practice, 2025, 28(23): 2950-2960.
|
[14] |
ZHOU Lianpeng, LI Weifeng, DONG Xingang, WANG Xiaoyuan.
Research Progress on the Role of Copper Homeostasis Regulation Mechanism in Cognition Disorder
[J]. Chinese General Practice, 2025, 28(23): 2941-2949.
|
[15] |
LIU Yueying, WANG Xueli, LIU Yuqiu, WEI Limin.
Correlation of Fasting C-peptide to Diabetes Duration Ration and Type 2 Diabetes Mellitus Combined with Metabolism-related Fatty Liver Disease
[J]. Chinese General Practice, 2025, 28(23): 2852-2860.
|